TMO - Thermo Fisher Scientific Inc

Healthcare - Sector

TMO is currently covered by 18 analysts with average potential upside of $49.83 (13.82%) backed by 174 price targets and 218 ratings. Analyst's average stock valuation to be materialised ratio is 80.47% with an average time for price targets to be met of 163.81 days.

Most recent stock forecast was given by CATHERINE RAMSEY SCHULTE from BAIRD on 01-Nov-2022.

Highest price target for TMO is 655, Lowest price target is 444, average price target is 549.5.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

665

$113.75 (20.63%)

657

27 days ago

11/12 (91.67%)

$42.47 (9.65%)

79

Buy

575

$23.75 (4.31%)

595

1 months 1 days ago

1/6 (16.67%)

$86.43 (16.40%)

142

Buy

650

$98.75 (17.91%)

715

1 months 1 days ago

11/15 (73.33%)

$66.39 (15.45%)

97

Buy

555

$3.75 (0.68%)

650

1 months 1 days ago

13/18 (72.22%)

$41.74 (11.10%)

137

Buy

613

$61.75 (11.20%)

678

1 months 1 days ago

2/6 (33.33%)

$84.1 (15.72%)

135

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login